2. Value Proposition: Death and Taxes
• Forget taxes…
• Death is the next big biotechnology
target!
• This is not just disruptive technology…
this is rude and recalcitrant technology!
3. Our Products
• AgeRegress reverses the aging process.
Single dose.
• Wide applications in human, veterinary,
and food science.
• AgeHalt stops the aging process. Daily
dosing.
• Ideal chronic use profile
7. Summary of Next 500 Science Slides
• Very, very, very cool totally
incomprehensible technology that can
only be understood by highly
specialized PhD scientists and 25 year
old venture capitalists recently ejected
from business school who have
undergraduate degrees in medieval
history
9. Old Dog Model
• Housebreaking side effect
Tricks/day 0 Tricks/day 2
10. Additional Product Line Extensions
• Add to irrigation water for ever bearing
fruits and vegetables
• Replace greenhouses!
• Instant sushi: sprinkle yesterday’s fish
with the product
• Replace refrigeration!
11. AgeHalt
• Chronic use
• Recurrent revenue
• No danger of patients getting too young
to pay for product
12. AgeHalt Use
• Abrupt withdrawal symptoms:
– Women: use of blue hair rinses
– Men: Full Cleveland
– Trading in SUV for Oldsmobile
13. Financial Requirements
• $20 million through pre-clinicals: 2007
• $40 million Phase 1 and 2: 2012
• $200 million to market: 2020
• Cash flow positive in this century
• Liquidity event: IPO as soon as the
window opens
14. First round
• A $1 million investment gets:
1% of the company and
unlimited product supply for personal
use
15. Advisory Board Candidates
• Mel Brooks
• A Supreme Court Justice
• A prominent member of Congress
• Aging rock star
16. Our management team and
board of directors had over 400
years of biotechnology
experience until they became
overinvolved in product
development
